{
  "page_summary": "This page provides descriptions of breast cancer assessments related to lymph node status, the number and size of positive lymph nodes, residual cancer burden (RCB), and histopathologic tumor grading systems. These measures are used in staging and prognostication, particularly after neoadjuvant therapy, but are described in a narrative manner without presenting them as formal study endpoints.",
  "endpoint_candidates": []
}